All relevant data are within the paper and its Supporting Information files.

Introduction {#sec005}
============

Coronary artery disease (CAD) is the leading cause of mortality worldwide \[[@pone.0164151.ref001]\]. CAD and its clinical manifestations are etiologically complex, with approximately equal contributions from genetic and environmental factors \[[@pone.0164151.ref002],[@pone.0164151.ref003]\]. Genetic risk scores derived from several functionally relevant single nucleotide polymorphisms (SNPs) or haplotypes in several genes may help in predicting CAD \[[@pone.0164151.ref004]\]. Associations of only a few common SNPs with CAD have been consistently replicated in several studies \[[@pone.0164151.ref005]\]. Both genome-wide association studies and candidate-gene approaches have identified a number of novel chromosome loci or genes that are associated with CAD \[[@pone.0164151.ref006],[@pone.0164151.ref007]\]. However, they account for relatively small portion of the overall CAD risk; therefore, there is a need for identification of novel loci or genes for CAD. Cholesteryl ester transfer protein (*CETP*) gene is localized on chromosome 16, which is of 21995 base pairs (bp) in size and consists of 16 exons (Gene ID 1071).CETP is a hydrophobic glycoprotein which plays a major role in RCT (Reverse Cholesterol Transport) from tissues to the liver. By enabling transfer of cholesteryl esters from high-density lipoproteins (HDL) to low density lipoproteins (LDL) and very low density lipoproteins (VLDL) lipoproteins *CETP* enables remodeling of plasma lipoproteins \[[@pone.0164151.ref008]\]. The elevated level of HDL cholesterol (HDL-C) is shown to be a protective factor for coronary artery disease from many epidemiological studies \[[@pone.0164151.ref009]\].Our earlier studies have suggest that Indian populations are unique in their origin and practicing endogamy for the past thousands of years, hence expected to have unique set of mutation which led to several disease, cardiac disease in particular \[[@pone.0164151.ref010]--[@pone.0164151.ref012]\].

Among the fastest growing non-communicable diseases, cardiovascular diseases (CVDs) are expected to cause largest number of mortality and morbidity within India \[[@pone.0164151.ref013]\]. Indians possess a unique lipid profile characterized by high triglycerides, low high-density lipoprotein (HDL), and increased lipoprotein (a) levels \[[@pone.0164151.ref014]\]. *CETP* plays a major role in HDL metabolism and this gene possesses several SNPs that have been reported to be associated with plasma HDL concentrations. However, this gene has not been analysed on Indian population, hence this study was aimed to investigate whether *CETP* gene variations influence CAD in South Indian population.

Materials and Methods {#sec006}
=====================

2.1. Sample details {#sec007}
-------------------

The study subjects composed of 323 CAD patients with coronary atherosclerosis and 300 age and ethnically matched healthy controls from South India. Blood samples were collected from Yashoda Hospital and Nizam Institute of Medical Sciences (NIMS), Hyderabad, India. Clinical manifestation of coronary atherosclerosis was evaluated by precutaneous coronary angiography, by a panel of experienced cardiologists. All ethnically matched control individuals were free from CAD, as determined by medical history, clinical examinations, or electrocardiography. Among CAD patients, 70% were males and 30% were females, while among the healthy control group 76% were male and 24% were female. The mean age of healthy controls was 65.26±10.30 years while that of patients was 56.21±10.45 years. In CAD patients; 18.57% were tobacco chewers, while it was 10% among the healthy controls. The demographic details of the individuals included in the study are given in **[Table 1](#pone.0164151.t001){ref-type="table"}**.

10.1371/journal.pone.0164151.t001

###### Clinical detail of individuals included in the study.

![](pone.0164151.t001){#pone.0164151.t001g}

  Clinical details                        Controls                  CAD patients               P-value (test)
  --------------------------------------- ------------------------- -------------------------- ------------------
  Number of samples                       300                       323                        \-
  Linguistic affiliation                  Dravidian (Telugu)        Dravidian (Telugu)         \-
  Sex (M:F)                               228(76%):72(24%)          226(70%):97(30%)           0.1045 (chisq)
  Age (years) at sampling (mean±S.D.)     65.26±10.30               56.21±10.45                2.36×10^−25^ (t)
  Tobacco (Y/N/%)                         30(10%) / 270(90%)        60(18.57%) /263(81.42%)    0.0029 (chisq)
  Alcohol (Y/N) (N/%)                     20(6.66%) / 280(93.33%)   43(13.31%) / 280(86.68%)   0.0075 (chisq)
  Hypertension (Y/N) (N/%)                NA                        180(55.72%)/55(44.27%)     \-
  Family history(Y/N) (N/%)               Nil                       170(52.63%) /153(47.36%)   \-
  Total cholesterol (mg/dl) (mean±S.D.)   150.5±30.8                212.5±40.8                 2.36×10^−76^ (t)
  Triglycerides (mg/dl) (mean±S.D.)       100.2±50.5                150.2±100.5                1.55×10^−14^ (t)
  HDL (mg/dl) (mean±S.D.)                 52.2±10.1                 39.2±20.9                  1.86×10^−21^ (t)
  LDL (mg/dl) (mean±S.D.)                 88.8±28.4                 98.8±50.4                  0.0022 (t)
  VLDL (mean±S.D.)                        16.2±13.4                 30.6±15.4                  5.20×10^−32^ (t)

M- Male; F- Female; S.D.-Standard deviation Y---yes; N---no; mg/dl milligram/deciliter; chisq--Chi-square test; t--T-test

We also utilized the genotype data of rs1801706/c.\*84G\>A of 1000 genome project's samples from Ensembl genome browser (version 84) ([asia.ensembl.org](http://asia.ensembl.org)).

2.2. Sample collection and DNA isolation {#sec008}
----------------------------------------

Prior to collection of blood samples, CAD patients were subjected to physical/clinical examinations such as 12 lead ECG and lipid profile, etc. Blood samples of healthy controls from the same ethnic background, without hypertension or CAD based on electrocardiograph were collected. A total of 10 ml intravenous blood samples of both cases and controls were collected in EDTA vaccutainer, after obtaining informed written consent. Genomic DNA was isolated from all the samples using standard protocol \[[@pone.0164151.ref015]\]. This study followed the principles outlined in the Declaration of Helsinki (WMA World Medical Association Declaration of Helsinki), and was approved by the Institutional Ethics Committee of Yashoda Hospital, Hyderabad; Nizam's Institute of Medical Sciences (NIMS), Hyderabad; and CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad, India.

2.3. Genotyping {#sec009}
---------------

The reference genomic sequence of *CETP* (ENSG00000087237) was obtained from the Ensemble database ([asia.ensembl.org](http://asia.ensembl.org)). Primers to amplify all the exons, and exon-intron boundaries of *CETP* were designed using Primer3 web version 4.0 (**[Table 2](#pone.0164151.t002){ref-type="table"}**). PCRs (polymerase chain reactions) were performed using GeneAmp 9700 (Applied Biosystems, Foster City, USA) using Emerald Amp GT PCR master mix (TaKaRa) according to the manufacturer\'s protocol. After PCR, Amplicons were size fractionated using2% agarose gel, stained with ethidium bromide and observed under UV transilluminator. Subsequently, amplicons were treated with Exo-SAP (USB Corp., USA), and sequenced using a BigDye Terminator (v3.1) cycle sequencing kit (Applied Biosystems, Foster City, USA) on an ABI 3730XL DNA analyzer. Sequences obtained were assembled with the reference sequences using AutoAssembler software (Applied Biosystems, Foster City, USA). Variations observed were noted for further analysis.

10.1371/journal.pone.0164151.t002

###### Sequence of primers used to amplify exons and exon-intron boundaries of *CETP* gene.

Annealing temperature of all the 12 set of primers are 60°C.
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  Exon \#   Forward Primer            Reverse Primer
  --------- ------------------------- -------------------------
  1         `TGCCCGGAAGAGCCTCATGTT`   `CTCTTCCAGGATCGACGTAAC`
  2         `CACTGCCCTCCCCTCTAG`      `GACCCCCATCCCTCCGCC`
  3         `CTTCCACCCTCGCCTAGACAA`   `AAGGACGAGCACGGGTAGGAC`
  4         `CATGGATGCACAGGACTGGTC`   `GTCTTCTGTCGTCACCCTCGG`
  5         `GCGGTGACTCAGGGCAATTC`    `TCAACCAGGAAAAAACACGA`
  6         `TCCCAATCTCCCTGAAGCTG`    `TGTGCGTACCCCTCCTCCCT`
  7         `TGCCCTTGGTCCCTGCGA`      `GTGTCGAGGATGAGCCAA`
  8         `CCCGGAGCCAGCTTTGTC`      `CTCCACCACCACCCCCTT`
  9         `TCCCGTGTCATCCTTGCC`      `CAGTCCGTGTCCCGCCCC`
  10        `GGAGGGCTGCCAGGAAGAAGG`   `ACTGGGAAGAAGAGGGACGGT`
  11        `TGGGGCAGGAAAACGGAGTG`    `ATGAATCGCCAGGACCGGGG`
  12        `GGTCCAAAAGGGTCTCAGCA`    `GCAGGTGGAGAAAAGTCGGG`

2.4. Statistical analysis and functional validation {#sec010}
---------------------------------------------------

Allele and genotype frequencies were calculated by the allele counting method. Statistical comparisons were carried out by Plink software \[[@pone.0164151.ref016]\].The P values less than 0.05 were considered for statistical significance. To explore the Hardy-Weinberg equilibrium (HWE), we consider genotype distribution in control samples and only those variants having HWE p value \> 0.05 were utilized in further association analysis.

Further, to explore the functional significant of mutant allele "A" of rs1801706 (c.\*84G\>A), we utilized the genome expression dataset GSE6536 of HapMap population from GEO (gene expression omnibus) database \[[@pone.0164151.ref017]\] and genotype data of *CETP* with ±10 kb flanking region from <ftp://ftp.ncbi.nlm.nih.gov/hapmap/genotypes/2009-01_phaseIII/plink_format/>. Further, we extracted the population-wise normalized expression value of *CETP* specific probe GI_4557442 from above downloaded GSE6536 dataset and performed quantitative trait association analysis using Plink software \[[@pone.0164151.ref016]\]. To explore the group-wise differences of mRNA level, we performed t-test using R. Moreover, to conclude the relation between higher mRNA concentrations with CAD patients, we utilized the relationship discussed in previous reports. On the basis of Barkowski, RS *et*. *al*. and Tan, MH \[[@pone.0164151.ref018],[@pone.0164151.ref019]\]; $${Concentration}_{HDL - C} \propto \frac{1}{{Concentration}_{mRNA - CETP}}$$ $${Risk}_{CAD} \propto \frac{1}{{Concentration}_{HDL - C}}$$

Hence, the genetic risk of CAD will be directly proportional to the mRNA concentration of *CETP*; $${Risk}_{CAD} \propto {Concentration}_{mRNA - CETP}$$

Results {#sec011}
=======

We have investigated the exons, exon-intron boundaries and UTR of *CETP* in 323 individuals with CAD and 300 ethnically matched controls. In total, we found thirteen variants (SNPs), of which one was in splice regions \[rs1532625 (C/T)\]; eight were in introns \[rs17231534 (C/A/T) and rs3816117 (T/C) rs711752 (G/A),rs9930761 (T/C), rs11076176 (T/G), rs289714 (G/A), rs1800774(C/T) and rs289741(G/A)\]; one was synonymous \[rs5883(C/T)\]; one was missense \[rs1800777 (G/A)\]; one was in 3' UTR \[rs1801706 (G/A)\]; and one was in the downstream position of gene \[rs289743 (G/C)\] (**[Table 3](#pone.0164151.t003){ref-type="table"} and [Fig 1](#pone.0164151.g001){ref-type="fig"}**).

![Observed variations and its location in *CETP* gene.mRNA.\
ENST00000200676 was utilized to represent the physical location of variants.](pone.0164151.g001){#pone.0164151.g001}
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###### Genotype and allele frequency distributions of SNPs in *CETP* among cases and controls.
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  SNP                               Gt/Al[^+^](#t003fn001){ref-type="table-fn"}   CAD(N/%) = 323   Control(N/%) = 300   OR (95% CI)            P-value        HWE P-value
  --------------------------------- --------------------------------------------- ---------------- -------------------- ---------------------- -------------- -------------
  **rs17231534(C/A)**               CC                                            263(81.42)       260(86.66)           1.48(0.94--2.35)       0.095          \~0
  **Intron variant**                CA                                            12(3.71)         17(5.66)                                                   
                                    AA                                            48(14.86)        23(7.66)                                                   
                                    C                                             574(88.85)       537(89.5)            1.07(0.74--1.55)       0.783          
                                    A                                             72(11.14)        63(10.5)                                                   
  **rs3816117(T/C)**                TT                                            115(35.60)       150(50)              1.81(1.30--2.53)       3.85E-04       \~0
  **Intron variant**                TC                                            98(30.34)        24(8)                                                      
                                    CC                                            110(34.05)       126(42)                                                    
                                    T                                             328(50.77)       324(54)              1.2(0.94--1.52)        0.146          
                                    C                                             318(49.22)       276(46)                                                    
  **rs711752(G/A)**                 GG                                            169(52.32)       152(50.66)           0.731(0.67--1.30)      0.731          \~0
  **Intron variant**                GA                                            89(27.55)        84(28)                                                     
                                    AA                                            65(20.12)        64(21.33)                                                  
                                    G                                             427(66.09)       388(64.66)           0.94(0.74--1.19)       0.0637         
                                    A                                             219(33.90)       212(35.33)                                                 
  **rs1532625(C/T)**                CC                                            99(30.65)        81(27)               0.84(0.58--1.20)       0.36           0.422
  **Splice region variant**         CT                                            128(39.62)       143(47.66)                                                 
                                    TT                                            96(29.72)        76(25.33)                                                  
                                    C                                             326(50.46)       305(50.83)           0.84(0.58--1.20)       0.36           
                                    T                                             320(49.53)       295(49.16)                                                 
  **rs9930761 (T/C)**               TT                                            300(92.87)       282(94)              1.2(0.61--2.38)        0.688          \~0
  **Intron variant**                TC                                            22(6.81)         14(4.66)                                                   
                                    CC                                            1(0.30)          4(1.33)                                                    
                                    T                                             622(96.28)       578(96.33)           1.01(0.54--1.90)       1              
                                    C                                             24(3.71)         22(3.66)                                                   
  **rs5883(C/T)**                   CC                                            305(94.42)       287(95.66)           1.3(0.59--2.88)        0.599          0.701
  **Synonymous variant**            CT                                            18(5.57)         13(4.33)                                                   
                                    TT                                            0(0)             0(0)                                                       
                                    C                                             628(97.21)       587(97.83)           1.29(0.60--2.82)       0.603          
                                    T                                             18(2.78)         13(2.16)                                                   
  **rs11076176 (T/G)**              TT                                            212(65.63)       192(64)              0.93(0.66--1.31)       0.732          1
  **Intron variant**                TG                                            101(31.26)       96(32)                                                     
                                    GG                                            10(3.09)         12(4)                                                      
                                    T                                             525(81.26)       480(80)              0.92(0.69--1.23)       0.621          
                                    G                                             121(18.73)       120(20)                                                    
  **rs289714 (G/A)**                GG                                            23(7.12)         12(4)                0.54(0.25--1.17)       0.129          0.436
  **Intron variant**                GA                                            98(30.34)        107(35.66)                                                 
                                    AA                                            202(62.53)       181(60.33)                                                 
                                    G                                             144(22.29)       131(21.83)           0.97(0.74--1.28)       0.99           
                                    A                                             502(77.70)       469(78.16)                                                 
  **rs1800774(C/T)**                CC                                            180(55.72)       163(54.33)           0.95(0.68--1.31)       0.788          0.0018
  **Intron variant**                CT                                            108(33.43)       101(33.66)                                                 
                                    TT                                            35(10.83)        36(12)                                                     
                                    C                                             468(72.44)       427(71.16)           0.87(0.69--1.10)       0.254          
                                    T                                             178(27.55)       173(28.83)                                                 
  **rs1800777 (G/A)**               GG                                            309(95.66)       295(98.33)           2.67(0.89--8.61)       0.089          \~0
  **Missense variant**              GA                                            14(4.33)         3(1)                                                       
                                    AA                                            0(0)             2(0.66)                                                    
                                    G                                             632(97.83)       593(98.83)           1.88(0.70--5.17)       0.25           
                                    A                                             14(2.16)         7(1.16)                                                    
  **rs289741(G/A)**                 GG                                            73(22.60)        58(19.33)            0.82(0.55--1.23)       0.367          0.933
                                    GA                                            159(49.22)       147(49)                                                    
                                    AA                                            91(28.17)        95(31.66)                                                  
                                    G                                             305(47.21)       263(43.83)           0.87(0.69--1.10)       0.254          
                                    A                                             341(52.78)       337(56.16)                                                 
  **rs1801706(G/A) (c.\*84G\>A)**   **GG**                                        **195(60.37)**   **230(76.66)**       **2.16(1.50--3.10)**   **1.88E-05**   **0.135**
  **3 prime UTR variant**                                                                                                                                     
                                    **GA**                                        **112(34.67)**   **62(20.66)**                                              
                                    **AA**                                        **16(4.95)**     **8(2.66)**                                                
                                    **G**                                         **502(77.70)**   **522(87)**          **1.92(1.40--2.63)**   **2.57E-05**   
  **rs289743 (G/C)**                **A**                                         **144(22.29)**   **78(13)**                                                 
  **Downstream gene variant**       GG                                            195(60.37)       183(61)              1.03(0.73--1.44)       0.938          0.000001
                                    GC                                            117(36.22)       81(27)                                                     
                                    CC                                            11(3.4)          36(12)                                                     
                                    G                                             507(78.48)       447(74.5)            0.8(0.61--1.05)        0.111          
                                    C                                             139(21.51)       153(25.5)                                                  

^+^Gt/Al- Genotype/Allele

Among these 13 variants, 6 were in HWE equilibrium (p\>0.05) (**[Table 3](#pone.0164151.t003){ref-type="table"}**). Of which, rs1801706 (c.\*84G\>A) was significantly associated with patients group. The 3' UTR variant c.\*84G\>A (G/A) showed a genotype distribution (%) of 60.37 (GG), 34.67 (GA) and 4.95 (AA) among individuals with CAD; whereas in controls the frequencies were 76.66 (GG), 20.66 (GA) and 2.66 (AA). Association analysis with genotype showed significant association with CAD (OR = 2.16, 95% CI: 1.50--3.10, p = 1.88x10^-5^). The allelic distribution showed 77.70% of 'G' and 22.29% of 'A' in cases and among the controls the G showed 87% and 'A' showed 13% with significant association of the 'A' allele with OR = 1.92, 95% CI; 1.40--2.63, p-value 2.57x10^-5^. Both genotype and allele distribution of *CETP* SNPs among cases and controls are given in **[Table 3](#pone.0164151.t003){ref-type="table"}**.Since, we did not observed LD differences between the cases and controls; we did not proceed for haplotype analysis.

3.1. Functional validation of rs1801706/c.\*84G\>A {#sec012}
--------------------------------------------------

To functionally validate the mutant allele "A" (c.\*84G\>A), we have utilized the whole genome gene-expression data of 210 HapMap samples \[[@pone.0164151.ref017], [@pone.0164151.ref020]\] and performed QTL analysis with genotype information of same individuals from HapMap project, with additive model (**[Table 4](#pone.0164151.t004){ref-type="table"}**) and observed variant rs1801706 in association with *CETP* mRNA level with p-value 7.09×10^−3^ (R^2^ = 0.029 and β = 0.2163) (**[Table 4](#pone.0164151.t004){ref-type="table"}**). The genotype and normalized mRNA intensity/expression value for c.\*84G\>A is given in **[S1 Table](#pone.0164151.s001){ref-type="supplementary-material"}**. Interestingly, both heterozygous (GA) and mutant homozygous (AA) genotype were found to influence the higher level of mRNA (**[Fig 2](#pone.0164151.g002){ref-type="fig"}**).We also explored pair-wise comparison of mRNA expression between genotypes and observed that mRNA expression level of genotype AA *vs*. AG (p-value = 0.3452) and genotype AA *vs*. GG (p-value = 0.2632) were not significant, while genotype AG *vs*. GG was significantly different (p-value = 0.0018).

![Expression data of *CETP* in HapMap population according to their genotype.\
Middle bar represents the mean value of expression while flanking bar represents their standard deviation.](pone.0164151.g002){#pone.0164151.g002}
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###### SNPs present within ±10kb of *CETP* and their respective association p-value with normalized mRNA expression level.

Only rs1801706 (c.\*84G\>A) was significantly associated and highlighted in bold.
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  Chr.     SNP             Physical position (hg19)   No. of subjects   β            S.E.         R2           T            P value
  -------- --------------- -------------------------- ----------------- ------------ ------------ ------------ ------------ ------------
  16       rs247617        56990716                   247               -0.0726      0.0691       0.0045       -1.0510      0.2943
  16       rs6499863       56992017                   247               0.0721       0.0739       0.0039       0.9758       0.3301
  16       rs3764261       56993324                   247               -0.1114      0.0658       0.0116       -1.6940      0.0916
  16       rs12447924      56994192                   245               -0.0866      0.0754       0.0054       -1.1490      0.2517
  16       rs4783961       56994894                   247               -0.0268      0.0605       0.0008       -0.4437      0.6577
  16       rs4783962       56995038                   247               0.0309       0.0788       0.0006       0.3914       0.6959
  16       rs1800775       56995236                   247               0.0567       0.0621       0.0034       0.9127       0.3623
  16       rs1864163       56997233                   242               -0.0122      0.0750       0.0001       -0.1622      0.8713
  16       rs7203984       56999258                   246               -0.1174      0.0590       0.0160       -1.9890      0.0478
  16       rs12597002      57002404                   247               0.0600       0.0692       0.0031       0.8676       0.3864
  16       rs891142        57003977                   246               -0.0751      0.1151       0.0017       -0.6527      0.5146
  16       rs12720860      57004662                   247               -0.3030      0.2037       0.0090       -1.4880      0.1382
  16       rs7205804       57004889                   241               -0.0097      0.0631       0.0001       -0.1542      0.8776
  16       rs1532624       57005479                   247               -0.0014      0.0633       0.0000       -0.0217      0.9827
  16       rs12708974      57005550                   247               0.1446       0.1023       0.0081       1.4130       0.1588
  16       rs12720872      57005882                   247               -0.2828      0.1833       0.0096       -1.5420      0.1243
  16       rs7499892       57006590                   247               -0.0666      0.0713       0.0035       -0.9338      0.3513
  16       rs9930761       57007192                   247               0.2321       0.1142       0.0166       2.0320       0.0432
  16       rs5883          57007353                   247               0.2106       0.1218       0.0121       1.7290       0.0850
  16       rs289714        57007451                   246               -0.0752      0.0615       0.0061       -1.2220      0.2230
  16       rs12691052      57007512                   247               0.0782       0.1787       0.0008       0.4374       0.6622
  16       rs289715        57008508                   247               -0.0864      0.0757       0.0053       -1.1410      0.2549
  16       rs4784744       57011185                   247               0.0464       0.0627       0.0022       0.7403       0.4598
  16       rs12720898      57011243                   247               0.1187       0.1088       0.0048       1.0910       0.2764
  16       rs891144        57011936                   247               0.0548       0.1076       0.0011       0.5094       0.6109
  16       rs12708980      57012379                   247               -0.1229      0.0669       0.0136       -1.8370      0.0675
  16       rs7195984       57015463                   247               -0.0709      0.0989       0.0021       -0.7172      0.4739
  16       rs5882          57016092                   247               -0.0677      0.0586       0.0054       -1.1560      0.2487
  16       rs5742907       57016150                   247               -0.7002      0.6914       0.0042       -1.0130      0.3122
  16       rs12596364      57016519                   247               0.0216       0.1514       0.0001       0.1425       0.8868
  16       rs289740        57016950                   244               -0.0694      0.1125       0.0016       -0.6172      0.5377
  16       rs9923854       57017002                   247               0.2583       0.1044       0.0244       2.4750       0.0140
  16       rs2228667       57017279                   247               0.0936       0.6928       0.0001       0.1350       0.8927
  16       rs2303790       57017292                   245               -0.2835      0.2478       0.0054       -1.1440      0.2537
  16       rs1800777       57017319                   246               -0.0417      0.2336       0.0001       -0.1783      0.8586
  16       rs5887          57017552                   243               -0.2041      0.2455       0.0029       -0.8316      0.4065
  **16**   **rs1801706**   **57017662**               **247**           **0.2163**   **0.0797**   **0.0292**   **2.7150**   **0.0071**
  16       rs289742        57017762                   247               -0.0577      0.0659       0.0031       -0.8752      0.3823
  16       rs289744        57018102                   247               0.0483       0.0588       0.0027       0.8209       0.4125
  16       rs12720917      57019392                   247               -0.0059      0.1335       0.0000       -0.0442      0.9648
  16       rs289745        57019532                   247               -0.0332      0.0614       0.0012       -0.5402      0.5895
  16       rs12934552      57021433                   246               -0.0941      0.1237       0.0024       -0.7610      0.4474
  16       rs289747        57023938                   247               0.0033       0.0659       0.0000       0.0498       0.9603
  16       rs17290922      57024317                   247               -0.0919      0.1334       0.0019       -0.6887      0.4917
  16       rs1566439       57024662                   247               0.0181       0.0590       0.0004       0.3075       0.7587

3.2. Prevalence of rs1801706/c.\*84G\>A {#sec013}
---------------------------------------

Further, we explored the frequency spectrum of rs1801706 (c.\*84G\>A) in other world populations, including Indians. We utilized the genotype dataset from 1000 genome project. We observed that only 3 populations were having frequency of \<0.1 forrs1801706-A variant; (1) 0.086 in CDX (Chinese Dai), (2) 0.078 in MXL (Mexicans) and (3) 0.029 in PEL (Peruvians) (**[Table 5](#pone.0164151.t005){ref-type="table"}).**

10.1371/journal.pone.0164151.t005

###### Frequency spectrum of allele and genotype of rs1801706/ c. \*84G\>A in case, control and different world populations.

![](pone.0164151.t005){#pone.0164151.t005g}

  Population                       Allele frequency (count)   Genotype frequency (count)                                 
  -------------------------------- -------------------------- ---------------------------- -------------- -------------- -------------
  **Case**                         0.777 (502)                0.2229 (144)                 0.6037 (195)   0.3467 (112)   0.0495 (16)
  **Control**                      0.87 (522)                 0.13 (78)                    0.7666 (230)   0.2066 (62)    0.0266 (8)
  **All population**               0.845 (4230)               0.155 (778)                  0.713 (1785)   0.264 (660)    0.024 (59)
  **South-Asians**                 0.786 (769)                0.214 (209)                  0.607 (297)    0.358 (175)    0.035 (17)
      BEB (Bengali)                0.791 (136)                0.209 (36)                   0.605 (52)     0.372 (32)     0.023 (2)
      GIH (Guajarati Indians)      0.801 (165)                0.199 (41)                   0.612 (63)     0.379 (39)     0.010 (1)
      ITU (Telugu)                 0.775 (158)                0.225 (46)                   0.588 (60)     0.373 (38)     0.039 (4)
      PJL (Punjabi)                0.771 (148)                0.229 (44)                   0.583 (56)     0.375 (36)     0.042 (4)
      STU (SriLankan Tamil)        0.794 (162)                0.206 (42)                   0.647 (66)     0.294 (30)     0.059 (6)
  **East-Asians**                  0.895 (902)                0.105 (106)                  0.810 (408)    0.171 (86)     0.020 (10)
      CDX (Chinese Dai)            0.914 (170)                0.086 (16)                   0.828 (77)     0.172 (16)     0.0 (0))
      CHB (Han Chinese)            0.883 (182)                0.117 (24)                   0.796 (82)     0.175 (18)     0.029 (3)
      CHS (Southern Han Chinese)   0.900 (189)                0.100 (21)                   0.829 (87)     0.143 (15)     0.029 (3)
      JPT (Japanese)               0.880 (183)                0.120 (25)                   0.788 (82)     0.183 (19)     0.029 (3)
      KHV (Kinh)                   0.899 (178)                0.101 (20)                   0.808 (80)     0.182 (18)     0.010 (1)
  **African**                      0.846 (1119)               0.154 (203)                  0.717 (474)    0.259 (171)    0.024 (16)
      ACB (Caribbeans)             0.854 (164)                0.146 (28)                   0.719 (69)     0.271 (26)     0.010 (1)
      ASW (Afro-Americans)         0.885 (108)                0.115 (14)                   0.770 (47)     0.230 (14)     0.0 (0))
      ESN (Esan)                   0.843 (167)                0.157 (31)                   0.707 (70)     0.273 (27)     0.020 (2)
      LWK (Luhya)                  0.808 (160)                0.192 (38)                   0.657 (65)     0.303 (30)     0.040 (4)
      MAG (Mandinka)               0.858 (194)                0.142 (32)                   0.761 (86)     0.195 (22)     0.044 (5)
      MSL(Mende)                   0.865 (147)                0.135 (23)                   0.741 (63)     0.247 (21)     0.012 (1)
      YRI (Yoruba)                 0.829 (179)                0.171 (37)                   0.685 (74)     0.287 (31)     0.028 (3)
  **American**                     0.905 (628)                0.095 (66)                   0.821 (285)    0.167 (58)     0.012 (4)
      CLM (Colombians)             0.878 (165)                0.122 (23)                   0.787 (74)     0.181 (17)     0.032 (3)
      MXL(Mexicans)                0.922 (118)                0.078 (10)                   0.844 (54)     0.156 (10)     0.0 (0))
      PEL (Peruvians)              0.971 (165)                0.029 (5)                    0.941 (80)     0.059 (5)      0.0 (0))
      PUR (Puerto Ricans)          0.865 (180)                0.135 (28)                   0.740 (77)     0.250 (26)     0.010 (1)
  **Europeans**                    0.807 (812)                0.193 (194)                  0.638 (321)    0.338 (170)    0.024 (12)
      CEU (Utah residents)         0.778 (154)                0.222 (44)                   0.586 (58)     0.384 (38)     0.030 (3)
      FIN (Finnish)                0.813 (161)                0.187 (37)                   0.657 (65)     0.313 (31)     0.030 (3)
      GBR (British)                0.797 (145)                0.203 (37)                   0.626 (57)     0.341 (31)     0.033 (3)
      IBS (Iberian)                0.822 (176)                0.178 (38)                   0.654 (70)     0.336 (36)     0.009 (1)
      TSI (Toscani)                0.822 (176)                0.178 (38)                   0.664 (71)     0.318 (34)     0.019 (2)

Discussion {#sec014}
==========

CAD is caused by multiple genetic and environmental factors \[[@pone.0164151.ref002]\].*CETP* plays a central role in human lipoprotein metabolism, as it facilitates the removal of excess cholesterol from the body via LDL receptor-mediated uptake in the liver and excretion into the bile \[[@pone.0164151.ref021]\]. Our earlier study on the -629 promoter of *CETP* gene had shown a significant association between CAD patients and controls \[[@pone.0164151.ref022]\]. Considering the crucial role of *CETP* in lipid metabolism, we investigated the association of genetic variants of the *CETP* with risk of coronary artery disease in patients from South India.

In the present study, we observed a 3' UTR variant, rs1801706 (c.\*84G\>A) is associated with the CAD in South Indians, however, we did not find association of a few previously reported SNPs. A genome-wide linkage analysis conducted on healthy American woman cohort had analyzed over 350,000 SNPs and found only SNPs flanking or in the *CETP* gene were associated with both HDL-C and risk of incident CAD \[[@pone.0164151.ref023]\].Papp *et*.*al*. observed that rs5883*T*/rs9930761*C* was associated with increased HDL-C levels in males \[[@pone.0164151.ref024]\]. Although our study group had 76% males, we did not find any significant association with rs5883. Studies on C\>T/In9 (rs289714) was earlier shown to be associated with undesirable changes in adiposity and HDL-C levels when exposed to excessive calorie consumption \[[@pone.0164151.ref025],[@pone.0164151.ref026]\], however, we did not find significant association between cases and the controls. Studies on Caucasians and African Americans \[[@pone.0164151.ref027]\] showed association of *CETP* variations with myocardial infarction (MI).

The rs1800777 (Arg 451Gln) is located within the lipid-binding region of *CETP* protein and possibly may result in the loss of positive charge, varying the binding efficiency of *CETP* to cholesteryl esters. Lu *et al*. reported that rs1800777was associated with lower plasma HDL cholesterol levels \[[@pone.0164151.ref028]\], whereas Moleres *et al*. reported that this SNP is strongly associated with adiposity indexes \[[@pone.0164151.ref029]\]. However, in the present study both the genotype and allele frequency of this variant did not show any association with CAD. Interestingly, we found rs1801706 (c.\*84G\>A) was significantly associated with CAD, which is in agreement with Whitehall II *et al*.

Since, associated variant rs1801706 (c.\*84G\>A) was observed in UTR region, we predicted that mutant allele "A" might be affecting mRNA expression of *CETP*. Here, we were not aware that mutant allele "A" increasing or decreasing the expression. But, using [Eq 2](#pone.0164151.e003){ref-type="disp-formula"}, it can be further predicted that mutant allele "A" should increase the expression because risk of CAD increases with expression level and patients were having higher frequency of "A". Interestingly, in QTL analysis, we observed that our prediction is true.

It is well known that inhibition of *CETP* decrease LDL level while increase the HDL, vice-versa might be true. We can predict that high expression of *CETP*, due to mutant allele "A", is responsible for high LDL level in CAD patients. This might be the reason of plague formation in blood vessels and further causing coronary artery disease.

Further, data obtained for rs1801706 (c.\*84G\>A) from the 1000 genome project revealed that only 3 populations were having frequency of\<0.1; (1) 0.086 in CDX (Chinese Dai), (2) 0.078 in MXL (Mexicans) and (3) 0.029 in PEL (Peruvians) (**[Table 5](#pone.0164151.t005){ref-type="table"}**). Populations with Indian ancestry (GIH, STU, ITU and BEB) have higher frequency of this allele compared to the controls. This might be due to the admixture of migrant Indians with local populations, who might have higher frequency of rs1801706-A allele (Europeans population in 1000 genome project).

Conclusion {#sec015}
==========

In conclusion, our study revealed rs1801706 (c.\*84G\>A), a functionally relevant variant in 3' UTR of *CETP*, is strongly associated with CAD in South Indian. Interestingly, mutant allele "A" was found to be associated with higher concentration of *CETP* mRNA. Since, *CETP* involve in the conversion of HDL to LDL/VLDL, we are tempted to conclude that rs1801706-A increases the risk of CAD by increasing rate of conversion of HDL to LDL/VLDL, through changing the half life of *CETP* mRNA.

Supporting Information {#sec016}
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###### Details of normalized expression value of *CETP* mRNA with genotype of rs1801706/c.

\*84G\>A in same samples of HapMap populations.

(DOCX)
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Click here for additional data file.
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